首頁 › 急性髓系白血病 › 南卡羅來納州 › Charleston
Charleston, SC 的 急性髓系白血病 臨床試驗
10 項針對 急性髓系白血病 的研究正在 Charleston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
招募中2 期
- Medical University of South Carolina, Charleston
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
招募中2 期
- Medical University of South Carolina, Charleston
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
招募中2 期
- Medical University of South Carolina, Charleston
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
招募中3 期
- Medical University of South Carolina, Charleston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
招募中2 期
- MUSC Health University Medical Center, Charleston
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
招募中1/2 期
- Medical University of South Carolina, Charleston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中觀察性研究
- Medical University of South Carolina, Charleston
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
招募中1 期
- Medical University of South Carolina, Charleston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
招募中2/3 期
- Hollings Cancer Center, Charleston
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
招募中1/2 期
- Medical University of South Carolina, Charleston
其他城市的 急性髓系白血病 試驗
- Houston, TX85 項研究
- New York City, NY51 項研究
- Boston, MA44 項研究
- Seattle, WA41 項研究
- Baldwin Park, CA40 項研究
- Columbus, OH35 項研究
- Philadelphia, PA34 項研究
- Durham, NC33 項研究
- Atlanta, GA31 項研究
- Tampa, FL29 項研究
- Chicago, IL26 項研究
- Portland, OR25 項研究
Charleston 的其他研究
- 憂鬱症19 項研究
- 中風18 項研究
- 心臟衰竭18 項研究
- 非小細胞肺癌16 項研究
- 創傷後壓力症候群16 項研究
- 心血管疾病15 項研究
- 前列腺癌15 項研究
- 癌症（所有類型）14 項研究
- 頭頸部鱗狀細胞癌14 項研究
- 帕金森氏症13 項研究
- 間質性肺病13 項研究
- 乳癌12 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。